Neurocrine Biosciences Inc (NBIX):企業の財務・戦略的SWOT分析

◆英語タイトル:Neurocrine Biosciences Inc (NBIX) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1165
◆発行会社(調査会社):GlobalData
◆発行日:2020年3月
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Neurocrine Biosciences Inc (NBIX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Neurocrine Biosciences Inc (Neurocrine) discovers, develops and commercializes pharmaceutical products for the treatment of neurologic, psychiatric and endocrine related diseases and disorders. Its lead product, Ingrezza (valbenazine) capsule is a US FDA approved selective vesicular monoamine transporter 2 inhibitor for the treatment of adults with tardive dyskinesia (TD). Its other major pipeline products include elagolix, a gonadotropin-releasing hormone (GnRH) antagonist for the treatment of endometriosis and uterine fibroids and opicapone, a catechol-O-methyltransferase inhibitor (COMT inhibitor) intended for adult patients with Parkinson’s disease. It also develops drug candidates for the treatment of essential tremor and classic congenital adrenal hyperplasia. Neurocrine is headquartered in San Diego, California, the US.

Neurocrine Biosciences Inc Key Recent Developments

Feb 04,2020: Neurocrine Biosciences reports fourth quarter and full-year 2019 financial results
Feb 03,2020: Neurocrine Biosciences announces appointment of Shalini Sharp to Board of Directors
Jan 12,2020: Neurocrine Biosciences provides preliminary fourth quarter and full-year 2019 net product sales results and 2020 program Milestones
Dec 03,2019: Neurocrine enters $1.7bn epilepsy therapies deal with Xenon
Nov 04,2019: Neurocrine Biosciences reports third quarter 2019 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Neurocrine Biosciences Inc – Key Facts
Neurocrine Biosciences Inc – Key Employees
Neurocrine Biosciences Inc – Key Employee Biographies
Neurocrine Biosciences Inc – Major Products and Services
Neurocrine Biosciences Inc – History
Neurocrine Biosciences Inc – Company Statement
Neurocrine Biosciences Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Neurocrine Biosciences Inc – Business Description
Neurocrine Biosciences Inc – Corporate Strategy
Neurocrine Biosciences Inc – SWOT Analysis
SWOT Analysis – Overview
Neurocrine Biosciences Inc – Strengths
Neurocrine Biosciences Inc – Weaknesses
Neurocrine Biosciences Inc – Opportunities
Neurocrine Biosciences Inc – Threats
Neurocrine Biosciences Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Neurocrine Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Neurocrine Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Neurocrine Biosciences Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 04, 2020: Neurocrine Biosciences reports fourth quarter and full-year 2019 financial results
Feb 03, 2020: Neurocrine Biosciences announces appointment of Shalini Sharp to Board of Directors
Jan 12, 2020: Neurocrine Biosciences provides preliminary fourth quarter and full-year 2019 net product sales results and 2020 program Milestones
Dec 03, 2019: Neurocrine enters $1.7bn epilepsy therapies deal with Xenon
Nov 04, 2019: Neurocrine Biosciences reports third quarter 2019 financial results
Sep 30, 2019: Neurocrine Biosciences appoints David W. Boyer as Chief Corporate Affairs Officer
Sep 11, 2019: Neurocrine Biosciences announces appointment of Leslie V. Norwalk to board of directors
Jul 29, 2019: Neurocrine Biosciences reports second quarter 2019 financial results
Apr 29, 2019: Neurocrine Biosciences reports first quarter 2019 financial results
Jan 30, 2019: Voyager signs $1.8bn drug development deal with Neurocrine
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Neurocrine Biosciences Inc, Key Facts
Neurocrine Biosciences Inc, Key Employees
Neurocrine Biosciences Inc, Key Employee Biographies
Neurocrine Biosciences Inc, Major Products and Services
Neurocrine Biosciences Inc, History
Neurocrine Biosciences Inc, Subsidiaries
Neurocrine Biosciences Inc, Key Competitors
Neurocrine Biosciences Inc, Ratios based on current share price
Neurocrine Biosciences Inc, Annual Ratios
Neurocrine Biosciences Inc, Annual Ratios (Cont...1)
Neurocrine Biosciences Inc, Annual Ratios (Cont...2)
Neurocrine Biosciences Inc, Interim Ratios
Neurocrine Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Neurocrine Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Neurocrine Biosciences Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Neurocrine Biosciences Inc, Performance Chart (2015 - 2019)
Neurocrine Biosciences Inc, Ratio Charts
Neurocrine Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Neurocrine Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Neurocrine Biosciences Inc (NBIX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Keio University-製薬・医療分野:企業M&A・提携分析
    Summary Keio University (Keio) is an educational institution that offers academic and research in various fields. The university provides primary and secondary education, graduate and undergraduate courses, and information technology courses. It offers academic courses in the field of economics, law …
  • Ya-Man Ltd:企業の戦略・SWOT・財務分析
    Ya-Man Ltd - Strategy, SWOT and Corporate Finance Report Summary Ya-Man Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Patanjali Ayurved Ltd:企業の戦略的SWOT分析
    Patanjali Ayurved Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Cambridge Research Biochemicals Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Cambridge Research Biochemicals Ltd (CRB) is a provider of custom peptide and custom antibody producer for research activities. The company offers products such as stock peptides, peptide nucleic acid, florescent dyes, and immunological products and labeling kits. Its immunological products …
  • Altadis U.S.A., Inc.:企業の戦略・SWOT・財務情報
    Altadis U.S.A., Inc. - Strategy, SWOT and Corporate Finance Report Summary Altadis U.S.A., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • MAB Discovery GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary MAB Discovery GmbH (MAB Discovery) is a drug discovery and development company that offers novel antibody therapeutics. The company produces monoclonal antibodies derived from rabbits and rats by employing biochemical and cellular based screens. It relies on natural immune response and B cel …
  • One Way Liver SL:医療機器:M&Aディール及び事業提携情報
    Summary One Way Liver SL (OWL), formerly One Way Liver Genomics SL is a biotechnology company that develops, discovers, and offers diagnostic products and metabolomics services for the healthcare sector. The company commercializes OWLiver that is a serum based test used for steatosis and NASH diagno …
  • Yoho Resources Inc. (YO)-石油・ガス分野:企業M&A・提携分析
    Summary Yoho Resources Inc. (Yoho) is an upstream oil and gas exploration company. The company carries out exploration, development and production of crude oil and natural gas liquid, and natural gas. The company has operations within the Western Canadian Sedimentary Basin focusing exploration activ …
  • Genzyme Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Genzyme Corp (Genzyme), a subsidiary of Sanofi, is a biotechnology company that develops specialty care treatments targeting rare diseases, oncology, immunology and multiple sclerosis. It offers products for the treatment of indications including various forms of cancer, mucopolysaccharidosi …
  • Basin Electric Power Cooperative:発電所・企業SWOT分析
    Basin Electric Power Cooperative - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • Skandinaviska Enskilda Banken AB:企業の戦略・SWOT・財務分析
    Skandinaviska Enskilda Banken AB - Strategy, SWOT and Corporate Finance Report Summary Skandinaviska Enskilda Banken AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Agro Tech Foods Limited:企業の戦略・SWOT・財務情報
    Agro Tech Foods Limited - Strategy, SWOT and Corporate Finance Report Summary Agro Tech Foods Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Kinnov Therapeutics SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Kinnov Therapeutics SAS (Kinnov) is a research and development company that discovers and develops therapies against addiction. The company provides pipeline product such as KT-110, a pharmaceutical composition used as a therapy for addiction diseases. Its antagonist of alpha1-adrenergic rec …
  • Sinocare Inc (300298):医療機器:M&Aディール及び事業提携情報
    Summary Sinocare Inc (Sinocare) is a medical device company that focuses on the research, development, manufacturing and commercialization of diagnosis testing products for diabetes and other chronic diseases. Its product portfolio comprises mobile glucose meter, portable automatic biochemical analy …
  • Sir Robert McAlpine Ltd:企業の戦略的SWOT分析
    Sir Robert McAlpine Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • IntegraGen SA (ALINT):医療機器:M&Aディール及び事業提携情報
    Summary IntegraGen SA (IntegraGen) is a developer and commercializer of molecular diagnostic tests for the treatment of autism and oncology. The company provides advanced genomic and bioinformatic services, including clinical research, basic and human genetic research, bioinformatics and bioanalysis …
  • QuickLogic Corporation (QUIK):企業の財務・戦略的SWOT分析
    QuickLogic Corporation (QUIK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Mizuho Financial Group Inc
    Mizuho Financial Group Inc - Strategy, SWOT and Corporate Finance Report Summary Mizuho Financial Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • The Hokkaido Bank Ltd:企業の戦略・SWOT・財務情報
    The Hokkaido Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Hokkaido Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Ggp Inc:企業の戦略・SWOT・財務分析
    Ggp Inc - Strategy, SWOT and Corporate Finance Report Summary Ggp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆